Breaking Biotech

010 - Zafgen delivers in Type 2 Diabetes. Tandem announces FDA approval!


Listen Later

Today I breakdown Zafgen's problematic history with an update on their newest generation of MetAP2 inhibitors for treatment of Type 2 Diabetes. I also talk about Tandem Diabetes Care and their latest FDA approval. Follow me on twitter @matthewlepoire Relevant links: http://zafgen.gcs-web.com/news-releases/news-release-details/zafgen-announces-positive-full-results-phase-2-proof-concept http://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-announces-fda-approval-tslim-x2-insulin This is not investment advice
...more
View all episodesView all episodes
Download on the App Store

Breaking BiotechBy Matthew Lepoire

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

24 ratings